Chemical
CAS: 21256-18-8
3-(4,5-Diphenyloxazol-2-yl)propanoic acid
Oxaprozin
Formula: C18H15NO3
Specifications
Key details (from tblproducts)
| CAS | 21256-18-8 |
| Molecular formula | C18H15NO3 |
| Molecular weight | 293.32 |
| IUPAC | 3-(4,5-Diphenyloxazol-2-yl)propanoic acid |
| Smileys | O=C(O)CCC1=NC(C=2C=CC=CC2)=C(O1)C=3C=CC=CC3 |
Supplier listings below are pulled from tblproductsupplier + tblsuppliers.
Suppliers
Suppliers offering this product
| Supplier | Country | Stock | Action |
|---|---|---|---|
| Clearsynth | India | In Stock | View |
| TLC Pharmaceutical Standards Ltd | Canada | In Stock | View |
| Key Organics | United Kingdom | In Stock | View |
| Toronto Research Chemicals | Canada | In Stock | View |
| USP | INDIA | In Stock | View |
| USP | INDIA | In Stock | View |
| Alsachim | FRANCE | In Stock | View |
| Artis Biotech India LLP | India | In Stock | View |
| AvaChem Scientific | United States | In Stock | View |
| Avanscure Lifesciences Pvt Ltd | INDIA | In Stock | View |
| Fluorochem Ltd | United Kingdom | In Stock | View |
| Parchem | United States | In Stock | View |
| R & S Chemicals | India | In Stock | View |
| RXN CHEMICALS PVT. LTD. | INDIA | In Stock | View |
| Synthese AptoChem Inc | Canada | In Stock | View |
| Targetmol | United States | — | View |
| TCASChem Tech Co Ltd | CHINA | In Stock | View |
| AptoChem | Canada | In Stock | View |
| Bridge Bioservice LLC | United States | — | View |
| Changzhou Tigar Fine Chemical Co., Ltd. | China | — | View |
| Dalian Teloon Chemical Co. | China | — | View |
| DSL Chemicals (Shanghai) Co., Ltd. | CHINA | In Stock | View |
| farchemia srl | Italy | — | View |
| Generichem Corporation | United States | — | View |
| Hubei Biocause Pharmaceutical Co., Ltd | China | — | View |
| Katwijk Chemie B.V. | Netherlands | — | View |
| Key Organics Limited/Bionet Research | United Kingdom | In Stock | View |
| MEDIOCON INC. | India | In Stock | View |
| Teloon Chemicals Corporation Limited | China | — | View |
| Trustchem Company Limited | China | — | View |